iSpecimen | 8-K: Current report
Apr 12 04:15
iSpecimen | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 29 04:55
iSpecimen | 3: Initial statement of beneficial ownership of securities-Director Graham Elizabeth Ames
Mar 27 04:38
iSpecimen | 8-K: Current report
Mar 27 04:16
iSpecimen | 8-K: Current report
Mar 14 21:09
iSpecimen | 10-K: Annual report
Mar 14 05:30
iSpecimen | 8-K: Current report
Mar 5 22:28
iSpecimen | 424B5: Prospectus
Mar 5 22:28
iSpecimen | 8-K: Current report
Feb 16 06:13
iSpecimen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OBF Investments, LLC(9.3%),George H. Scholl(9.3%)
Feb 14 11:15
iSpecimen | 5: Annual statement of changes in beneficial ownership of securities-Director Mock Theresa L
Feb 9 05:25
iSpecimen | 8-K: Current report
Dec 22, 2023 05:15
iSpecimen | 8-K: iSpecimen Reports Third Quarter 2023 Financial and Operating Results
Nov 2, 2023 21:01
iSpecimen: Q3 2023 Earnings Report
Nov 2, 2023 18:30
iSpecimen | 8-K: Current report
Oct 23, 2023 19:45
iSpecimen | 8-K: Current report
Oct 11, 2023 05:29
iSpecimen | 4: Statement of changes in beneficial ownership of securities-Officer Bielak Benjamin
Sep 16, 2023 04:23
iSpecimen | 8-K: Current report
Sep 7, 2023 04:16
iSpecimen | 8-K: iSpecimen Reports Second Quarter 2023 Financial and Operating Results
Aug 2, 2023 21:15
iSpecimen | 10-Q: Q2 2023 Earnings Report
Aug 2, 2023 18:30
No Data
No Data